BIOMAT Database Logo BIOMAT Database Logo

Hepatitis A protein VP1-2A reduced cell viability in Huh-7 cells with hepatitis C virus subgenomic RNA replication. 2006

Tatsuo Kanda, and Osamu Yokosuka, and Fumio Imazeki, and Keiichi Fujiwara, and Hiromitsu Saisho

UI MeSH Term Description Entries
D012093 Replicon Any DNA sequence capable of independent replication or a molecule that possesses a REPLICATION ORIGIN and which is therefore potentially capable of being replicated in a suitable cell. (Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Replication Unit,Replication Units,Replicons,Unit, Replication,Units, Replication
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015678 Viral Structural Proteins Viral proteins that are components of the mature assembled VIRUS PARTICLES. They may include nucleocapsid core proteins (gag proteins), enzymes packaged within the virus particle (pol proteins), and membrane components (env proteins). These do not include the proteins encoded in the VIRAL GENOME that are produced in infected cells but which are not packaged in the mature virus particle,i.e. the so called non-structural proteins (VIRAL NONSTRUCTURAL PROTEINS). Polypeptide VP1, Structural,VP(1),VP(2),VP(3),VP(6),VP(7),Viral Structural Proteins VP,Virus Structural Proteins,Proteins, Viral Structural,Proteins, Virus Structural,Structural Polypeptide VP1,Structural Proteins, Viral,Structural Proteins, Virus,VP1, Structural Polypeptide
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus

Related Publications

Tatsuo Kanda, and Osamu Yokosuka, and Fumio Imazeki, and Keiichi Fujiwara, and Hiromitsu Saisho
Mathematical modeling of subgenomic hepatitis C virus replication in Huh-7 cells.
January 2007, Journal of virology,
Tatsuo Kanda, and Osamu Yokosuka, and Fumio Imazeki, and Keiichi Fujiwara, and Hiromitsu Saisho
Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harboring subgenomic replicons.
May 2003, Journal of virology,
Tatsuo Kanda, and Osamu Yokosuka, and Fumio Imazeki, and Keiichi Fujiwara, and Hiromitsu Saisho
Activation of interferon-stimulated response element in huh-7 cells replicating hepatitis C virus subgenomic RNA.
January 2005, Intervirology,
Tatsuo Kanda, and Osamu Yokosuka, and Fumio Imazeki, and Keiichi Fujiwara, and Hiromitsu Saisho
Dynamics of subgenomic hepatitis C virus replicon RNA levels in Huh-7 cells after exposure to nucleoside antimetabolites.
October 2003, Journal of virology,
Tatsuo Kanda, and Osamu Yokosuka, and Fumio Imazeki, and Keiichi Fujiwara, and Hiromitsu Saisho
Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells.
October 1993, Journal of virology,
Tatsuo Kanda, and Osamu Yokosuka, and Fumio Imazeki, and Keiichi Fujiwara, and Hiromitsu Saisho
Non-nucleoside benzimidazole-based allosteric inhibitors of the hepatitis C virus NS5B polymerase: inhibition of subgenomic hepatitis C virus RNA replicons in Huh-7 cells.
December 2004, Journal of medicinal chemistry,
Tatsuo Kanda, and Osamu Yokosuka, and Fumio Imazeki, and Keiichi Fujiwara, and Hiromitsu Saisho
Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees.
October 2002, Proceedings of the National Academy of Sciences of the United States of America,
Tatsuo Kanda, and Osamu Yokosuka, and Fumio Imazeki, and Keiichi Fujiwara, and Hiromitsu Saisho
Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon.
December 2003, Gastroenterology,
Tatsuo Kanda, and Osamu Yokosuka, and Fumio Imazeki, and Keiichi Fujiwara, and Hiromitsu Saisho
TAT peptides mediated small interfering RNA delivery to Huh-7 cells and efficiently inhibited hepatitis C virus RNA replication.
January 2009, Intervirology,
Tatsuo Kanda, and Osamu Yokosuka, and Fumio Imazeki, and Keiichi Fujiwara, and Hiromitsu Saisho
Inhibition of the subgenomic hepatitis C virus replicon in huh-7 cells by 2'-deoxy-2'-fluorocytidine.
February 2004, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!